









Markets
/
Stocks
/
nasdaq-naya
/

NAYA Biosciences Inc

NAYA

2.200USD

0.000

Close 09/19, 16:00（ET）Quotes delayed by 15 min

8.59MMarket Cap

LossP/E TTM



NAYA Biosciences Inc

2.200

0.000

Overview Company Financials Analysis

Income Statement

Cash Flow Statement

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q3

Total equity

Cash, cash equivalents and short-term investments

--471.59K

- Cash and cash equivalents

--471.59K

Receivables

--257.05K

-Accounts and notes receivable

--257.05K

Inventory

--241.54K

Prepaid expenses

--987.30K

Total current assets

--1.96M

Non-current assets

Net Fixed Assets

--2.76M

-Fixed Assets

--3.07M

-Accumulated depreciation

--308.26K

Goodwill and other intangible assets

--9.36M

Total non-current assets

--15.06M

Total assets

--17.02M

Liabilities

Current liabilities

-Other payables

--2.85M

Accrued expenses

--640.04K

Short-term debt and lease liabilities

--1.72M

-Short-term debt

--880.00K

Deferred liabilities

--562.40K

Other current liabilities

--3.41M

Total current liabilities

--8.66M

Non-current liabilities

Long-term debt and lease liabilities

--3.39M

-Long-term debt

--1.13M

-Long-term lease liabilities

--2.25M

Other non-current liabilities

--5.00M

Total non-current liabilities

--8.39M

Total liabilities

--17.04M

Shareholders' equity

Common equity

--55.87M

Retained earnings

---63.54M

Capital reserves

--55.87M

Total equity

---23.32K

Currency unit

USD

Audit opinions

--

KeyAI

